We supply high-quality, reliable APIs to leading generic formulations manufacturers
Symbiotica supplies high-quality, reliable APIs to leading generic formulations manufacturers and is the preferred API partner to pharmaceutical companies worldwide. Symbiotica thrives on the deep technical strengths proven over the last two decades in developing and manufacturing complex APIs.
Our dedication to excellence has been recognised through numerous achievements. We are the first company in Asia to receive the CEP for Dexamethasone Sodium Phosphate and have successfully obtained US FDA and Japan PMDA certifications. With a diverse portfolio of 80+ API products and over 15 new API products in development, we regularly supply our APIs to more than 80 countries and over 350 clients globally.
| Type | Product Name | Certifications | Enquire |
|---|---|---|---|
| Steroids | Beclomethasone Dipropionate |
CEP ‘25
|
|
|
CEP ‘25
|
|||
| Steroids | Betamethasone |
CEP ‘26
US DMF ‘26
|
|
|
CEP ‘26
US DMF ‘26
|
|||
| Steroids | Betamethasone Acetate |
CTD
|
|
|
CTD
|
|||
| Steroids | Betamethasone Dipropionate |
CEP
KDMF
US DMF
|
|
|
CEP
KDMF
US DMF
|
|||
| Steroids | Betamethasone Sodium Phosphate |
CEP
KDMF
US DMF ‘25
|
|
|
CEP
KDMF
US DMF ‘25
|
|||
| Steroids | Betamethasone Valerate |
CEP
KDMF
US DMF
|
|
|
CEP
KDMF
US DMF
|
|||
| Steroids | Budesonide |
CEP ‘25
US DMF ‘25
|
|
|
CEP ‘25
US DMF ‘25
|
|||
| Steroids | Clobetasol Propionate |
CEP
KDMF
US DMF
|
|
|
CEP
KDMF
US DMF
|
|||
| Steroids | Clobetasone Butyrate |
CEP ‘25
J-DMF
|
|
|
CEP ‘25
J-DMF
|
|||
| Steroids | Clostebol Acetate |
CTD
|
|
|
CTD
|
|||
Product
Disclaimer
No information in this brochure - including any reference to any product or service - constitutes an offer for sale, or should be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. Buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent-related liabilities. Products protected under valid patents in Malaysia are not available for commercial use but may be available for research and regulatory purposes.